Advertisement
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
Bush MRaath JPde Vos V, et al. Serum oxytetracycline levels in free-ranging male African elephants (Loxodonta africana) injected with a long-acting formulation. J Zoo Wild Med 1996; 27:382–385.
-
2.
Bush MStoskopf MKRaath JP, et al. Serum oxytetracycline concentrations in African elephant (Loxodonta africana) calves after long-acting formulation injection. J Zoo Wild Med 2000; 31:41–46.
-
3.
Dumonceaux GIsaza RKoch DE, et al. Pharmacokinetics and i.m. bioavailability of ceftiofur in Asian elephants (Elephas maximus). J Vet Pharmacol Ther 2005; 28:441–446.
-
4.
Lodwick LJDubach JMPhillips LG, et al. Pharmacokinetics of amikacin in African elephants (Loxodonta africana). J Zoo Wild Med 1994; 25:367–375.
-
5.
Maslow JNMikota SKZhu M, et al. Population pharmacokinetics of isoniazid in the treatment of Mycobaterium tuberculosis among Asian and African elephants (Elephas maximus and Loxodonta africana). J Vet Pharmacol Ther 2004; 27:1–7.
-
6.
Maslow JNMikota SKZhu M, et al. Pharmacokinetics of ethambutol (EMB) in elephants. J Vet Pharmacol Ther 2005; 28:321–323.
-
7.
Page CDMautino MDerendorf HD, et al. Comparative pharmacokinetics of trimethoprim-sulfamethoxazole administered intravenously and orally to captive elephants. J Zoo Wild Med 1991; 22:409–416.
-
8.
Rosin ESchultz-Darken NPerry B, et al. Pharmacokinetics of ampicillin administered orally in Asian elephants (Elepahus maximus). J Zoo Wild Med 1993; 24:515–518.
-
9.
Mikota SK. Therapeutics. In: Fowler MEMikota SK, eds. Biology, medicine, and surgery of elephants. Ames, Iowa: Blackwell, 2006;211–231.
-
11.
Hibbard BRobb EJChester ST, et al. Dose determination and confirmation of a long-acting formulation of ceftiofur (ceftiofur crystalline free acid) administered subcutaneously for the treatment of bovine respiratory disease. J Vet Pharmacol Ther 2002; 25:175–180.
-
12.
Hibbard BRobb EJChester ST, et al. Dose determination and concentration for ceftiofur crystalline-free acid administered in the posterior aspect of the ear for control and treatment of bovine respiratory disease. Vet Ther 2002; 3:22–30.
-
13.
Robb EJHibbard BFollis SL, et al. Duration of efficacy of ceftiofur crystalline free acid compared to tilmicosin when administered at various times before intratracheal Mannheimia haemolytica challenge in calves. Bovine Pract 2004; 38:177.
-
14.
Washburn KJohnson RClarke CR, et al. Penetration of ceftiofur into sterile vs. Mannheimia haemolytica–infected tissue chambers in beef calves after subcutaneous administration of ceftiofur crystalline free acid sterile suspension in the ear pinna. J Vet Pharmacol Ther 2005; 28:247–251.
-
15.
Dueger ELGeorge LWAngelos JA, et al. Efficacy of a long-acting formulation of ceftiofur crystalline-free acid for the treatment of naturally occurring infectious bovine keratoconjunctivitis. Am J Vet Res 2004; 65:1185–1188.
-
16.
Excede sterile suspension technical manual. New York: Pfizer Animal Health, 2004.
-
17.
Prescott JF. Beta-lactam antibiotics: cephalosporins. In: Giguère SPrescott JFBaggot JD, et al, eds. Antimicrobial therapy in veterinary medicine. 4th ed. Ames, Iowa: Blackwell Publishing, 2006;139–157.
-
18.
Excede sterile suspension for swine technical manual. New York: Pfizer Animal Health, 2004.
-
19.
Meyer SGiguere SRodriguez R, et al. Pharmacokinetics of intravenous ceftiofur sodium and concentration in body fluids of foals. J Vet Pharmacol Ther 2008; 32:309–316.
-
20.
Olsen JH. Antibiotic therapy in elephants. In: Fowler MEMiller RE, eds. Zoo and wild animal medicine current therapy. 4th ed. Philadelphia: WB Saunders Co, 1999;533–541.
-
21.
Bechert UChristensen JM. Pharmacokinetics of orally administered ibuprofen in African and Asian elephants (Loxodonta africana and Elephas maximus). J Zoo Wild Med 2007; 38:258–268.
-
22.
Hunter RPIsaza RKoch DE. Oral bioavailability and pharmacokinetic characteristics of ketoprofen enantiomers after oral and intravenous administration in Asian elephants (Elephas maximus). Am J Vet Res 2003; 64:109–114.
-
23.
Tell LHarrenstien LWetzlich S, et al. Pharmacokinetics of ceftiofur sodium in exotic and domestic avian species. J Vet Pharmacol Ther 1998; 21:85–91.
-
24.
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals. Informational supplement M31–A3. Vol 28. Wayne, Pa: Clinical and Laboratory Standards Institute, 2008.
-
25.
Gabrielsson JWeiner D. Pharmacokinetic concepts. In: Pharmacokinetic and pharmacodynamic data analysis. Concepts & applications. 3rd ed. Stockholm: Swedish Pharmaceutical Press, 2000;147.
-
26.
Jaglan PSKubicek MFArnold TS, et al. Metabolism of ceftiofur—nature of urinary and plasma metabolites in rats and cattle. J Agric Food Chem 1989; 37:1112–1118.
-
27.
Bechert UChristensen JMNguyen C, et al. Pharmacokinetics of orally administered phenylbutazone in African and Asian elephants (Loxodonta africana and Elephas maximus). J Zoo Wild Med 2008; 39:188–200.
-
28.
Mahrt CR. Safety of ceftiofur sodium administered intramuscularly in horses. Am J Vet Res 1992; 53:2201–2205.
Advertisement
Pharmacokinetics of a long-acting ceftiofur crystalline-free acid formulation in Asian elephants (Elephas maxim us)
Abstract
Objective—To determine the pharmacokinetics of a long-acting formulation of ceftiofur, ceftiofur crystalline-free acid (CCFA), following SC injection to Asian elephants (Elephas maxim us).
Animals—11 adult Asian elephants.
Procedures—Each elephant received CCFA (6.6 mg/kg, SC) in the area caudoventral to the base of an ear. Blood samples were collected from an ear vein immediately prior to and at 0.5, 1, 2, 4, 8, 12, 24, 36, 48, 72, 96, 120, 144, and 168 hours after CCFA administration. Plasma concentrations of desfuroylceftiofur acetamide (the acetamide derivative of ceftiofur) were measured via ultrahigh-pressure liquid chromatography–tandem mass spectrometry. Data were analyzed via a noncompartmental pharmacokinetics approach.
Results—The mean ± SD maximum plasma concentration of desfuroylceftiofur acetamide was 1.36 ± 0.74 μg/mL and was detected at 4718 ± 31.30 hours. The mean ± SD area under the curve from time 0 to infinity was 2278 ± 55.8 μg•h/mL, and the mean residence time from time 0 to infinity was 158.2 ± 90.2 hours. The terminal elimination half-life associated with the slope of the terminal phase had a harmonic mean ± pseudo-SD of 83.36 ± 30.01 hours.
Conclusions and Clinical Relevance—Elephants tolerated CCFA at a dose of 6.6 mg/kg, SC, well. Dosing recommendations will depend on the mean inhibitory concentration of ceftiofur for each bacterial pathogen. Desfuroylceftiofur acetamide concentrations remained > 0.25 μg/mL for the entire 168-hour study period, which suggested CCFA would provide clinically relevant antimicrobial activity against certain pathogens for 7 to 10 days.
Contributor Notes
Dr. Adkesson's present address is Chicago Zoological Society, Brookfield Zoo, 3300 Golf Rd, Brookfield, IL 60513.
Dr. Allender's present address is Department of Comparative Biosciences, College of Veterinary Medicine, University of Illinois, Urbana, IL 61802.
Supported by the Saint Louis Zoo and Pfizer Inc.
The authors thank Dr. Mitch Finnegan, Martha Fischer, and Jim Naelitz for technical assistance and G. Scott Grover for assistance with the bioanalytic assays.
Powered by PubFactory